MSH|^~\&|HIVE|R0A|LIMS|699X0|20241013103300+0000||OML^O21^OML_O21|urn:uuid:9612365d-52a4-4fab-87e7-8a09d753f095|T|2.5.1|||ALPID|1||9737383192^^^NHS^NH~1234567^^^R0A^MR||MANCHESTER^SANSA||19720921|F|||^^^^M13 9PLPV1|1|I|||||||||||||||||1001166717^^^R0AORC|NW|160171601^R0A-EPI^urn:oid:1.2.840.114350.1.13.861.1.7.2.798268^URI|1001166717^699X0^http://www.acme.org/servicerequest^URI||||||20250129|||C3456789^^Samuel^^^Darwin,^^^GMC|||||||||NOTFOUNDOBR|1|160171601^R0A-EPI^urn:oid:1.2.840.114350.1.13.861.1.7.2.798268^URI|1001166717^699X0^http://www.acme.org/servicerequest^URI|R240.1^^England-GenomicTestDirectory||20250129||||||||||C3456789^^Samuel^^^Darwin,^^^GMCNTE|1||Referral lab PLEASE do following tests:NTE|2||NTE|3||Test(s) required: WGSNTE|4||Sample type: BloodNTE|5||Transport used: Merlin CourierNTE|6||Tracking Number: ABC123NTE|7||Sample sent to: LWH GeneticsNTE|8||By: PDAY on: 02/04/25NTE|9||NTE|10||Speciality Requesting Clinician: PAEDSNTE|11||Test Group: NeurologyNTE|12||Ethnic Group: White BritishNTE|13||Patient is from consanguineous union? : UnknownNTE|14||Specimen Collection Status: Collect & send with orderNTE|15||Infection Risk: No Specific RiskNTE|16||Clinical details:NTE|17||NTE|18||TESTINGNTE|19||Contact/Bleep No: 123NTE|20||DG1|1||363349007^Malignant tumour of stomach^SNM3DG1|2||363349007^Malignant tumour of stomach^SNM3DG1|3||363349007^Malignant tumour of stomach^SNM3OBX|1|CE|GENEAP^GENETICS TEST PERFORMABLE^NWGMSA|||||||||||20250129103726+0000OBX|2|CE|230056^What Type of Referral Do You Require?^NWGMSA||1186936003^Storage of specimen (procedure)^|||||||||20250129103726+0000OBX|3|CE|281269004^High infection risk sample^SNM3||LA32-8^No^|||||||||20250129103726+0000OBX|4|FT|230016^Test Type^NWGMSA||Diagnostic Screen/Test|||||||||20250129103726+0000OBX|5|CE|77386006^Pregnancy^SNM3||LA33-6^Yes^|||||||||20250129103726+0000OBX|6|FT|231284^Please Select R240 Test(s):^NWGMSA||R240.1: Targeted variant testing|||||||||20250129103726+0000OBX|7|FT|231285^Please Select R242 Test(s):^NWGMSA||R242.1: Targeted variant testing|||||||||20250129103726+0000OBX|8|FT|230027^Email Addresses of Non-MFT Clinicians for Result Reports^NWGMSA||charu|||||||||20250129103726+0000OBX|9|CE|762911000000102^Informed consent given for treatment^SNM3||LA33-6^Yes^|||||||||20250129103726+0000OBX|10|FT|230037^Please Acknowledge That a DNA Sample Will be Stored in the Laboratory on Completion of Testing^NWGMSA||Acknowledged|||||||||20250129103726+0000OBX|11|FT|230039^Is the Person Ordering the Test the Referring Clinician^NWGMSA||No|||||||||20250129103726+0000OBX|12|FT|unknown^Name of Supervising Clinician^NWGMSA||DESHPANDE, CHARULATA|||||||||20250129103726+0000OBX|13|FT|97209-1^Shipment tracking number^LN||UK3096580215|||||||||20250129103726+0000OBX|14|CE|842009^Consanguinity^SNM3||LA32-8^No^|||||||||20250129103726+0000OBX|15|DT|161714006^Estimated date of delivery^SNM3||20250512103726+0000|||||||||20250129103726+0000SPM|1|25GEN-029GN00001&R0A|^1001166717&699X0|258580003^Whole blood specimen^SNM3|||||||||||||20250129103726+0000|||Y
